SkinHealth Systems (SKIN)
Builds professional aesthetic treatments around devices and proprietary consumables.
Something off on this page? Send us feedback.
Provides professional aesthetic devices and proprietary consumables centered on Hydrafacial, alongside SkinStylus microneedling and HydraScalp with Keravive. The device-and-consumables platform reaches providers through an omnichannel network and pairs its offerings with clinical validation.
Built around Hydrafacial, a professional hydradermabrasion treatment that uses a patented delivery system to cleanse, extract, and hydrate skin with proprietary solutions and serums. The portfolio also includes SkinStylus microneedling and HydraScalp with Keravive for scalp health.
Designs, develops, manufactures, markets, and sells aesthetic technologies and products through an omnichannel provider network. Its stated model combines advanced device technology, proprietary consumables, and clinical validation across a multi-brand treatment platform.
Hydrafacial remains the flagship brand. The operating lineage traces to Hydrafacial's creation of the hydradermabrasion category in 1997. The listed parent adopted the SkinHealth Systems name while retaining Nasdaq ticker SKIN.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| May 20, 2026 | Roth Capital | Reiterate | Rating: —Target: $3.50 | Target: $2 |
| May 1, 2026 | Canaccord Genuity | Reiterate | Rating: —Target: $1.25 | Target: $1 |
| Jan 14, 2026 | Jefferies | Target | Target: — | Target: $1.60 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $206.1M · Total debt $367.1M · Total assets $486.6M · Shareholders' equity $55.6M
- Revenue
- $72.1M
- Operating income
- $3.6M
- Net income
- −$2.7M
No dividends on record.
| Institutions | 51.81% | 67.42M shares | |
|---|---|---|---|
| 99 holders · as of Jun 30, 2026 | |||
| Insiders | 12.28% | 15.98M shares | |
| 11 holders · as of Aug 12, 2026 | |||
| Strategic holders | 5.00% | 6.51M shares | |
| 1 holder · as of Apr 20, 2026 | |||
| Other | 30.91% | 40.22M shares | |
| remainder | |||
130.14M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Capricorn Fund Managers LtdInstitution | 17.12% | 22.28M | as of Jun 30, 2026 |
FMR LLCInstitution | 7.84% | 10.20M | as of Jun 30, 2026 |
The Vanguard GroupInstitution | 7.38% | 9.60M | filed Feb 9, 2022 |
BlackRock, Inc.Institution | 6.54% | 8.52M | as of Jun 30, 2026 |
Millennium Management LLCInstitution | 5.79% | 7.54M | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- AbbVie
DiamondGlow provides professional dermabrasion and serum delivery
- InMode
RF microneedling and skin-treatment devices for aesthetic providers
- Bausch Health
Solta skin-rejuvenation and tightening devices for aesthetic practices
CompareAfter hours
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| SkinHealth Systems | $0.6734 | −0.27% | $87.5M | — | — | 0.3 | −7.8% |
| AbbVie | $265.01 | −0.10% | $467.37B | 74.5 | 17.5 | 7.3 | +10.2% |
| InMode | $14.45 | 0.00% | $833.5M | 11.8 | 10.9 | 2.2 | −0.0% |
| Bausch Health | $5.81 | +0.09% | $2.11B | — | 1.3 | 0.2 | +11.2% |
| Median | 43.2 | 10.9 | 2.2 | +10.2% |